Streetbeat News

Stock Prices

BKNG

EXPE

TCOM

TRIP

Analysts predict a positive outlook for Trip.com Group Limited (NASDAQ:TCOM), a leader in the Chinese travel sector, as the domestic travel market shows stronger-than-expected demand. The company reported Q2 profits of $89 million, beating analyst expectations, and an increase in sales of over 180% from the same year-ago period. Despite a recent increase in short-side bets on Trip.com’s stock, analysts maintain a Buy rating, with an average price target of $50. The company's stock is currently trading around $35.

Portfolio Pulse from Daniel Harrison

October 31, 2023 | 1:41 pm

AAVEUSD

ATOMUSD

AXSUSD

BTCUSD

BTTUSD

ETHUSD

RUNEUSD

XRPUSD

Bitcoin and Ethereum edged lower but remained above key levels. The S&P CoreLogic Case-Shiller 20-city home price index climbed 2.2% YoY in August. Arweave was the top gainer over the past 24 hours, while Render was the biggest loser. The global crypto market cap rose to $1.28 trillion, recording a 24-hour gain of 0.1%.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 1:37 pm

CSCO

ZBRA

Zebra Technologies Corp reported a Q3 FY23 net sales decline of 30.6% YoY to $956 million, beating the consensus of $926.34 million. The company's adjusted EPS of $0.87 beat the consensus of $0.81. Net sales in the EVM segment fell 31.4% YoY to $632 million, and in the AIT segment decreased by 25.8% YoY to $324 million. The company expects Q4 net sales to decrease between 32% - 36% YoY. ZBRA shares traded higher by 0.53% at $210.89 on the last check Tuesday.

Portfolio Pulse from Anusuya Lahiri

October 31, 2023 | 1:36 pm

IWM

XLC

The article discusses the uncertainty in the market, questioning whether it is a bull market or a bear market rally. It mentions the dip in the market, the reduction of the end-of-year target for the S&P 500 by Fundstrats Tom Lee, and the unstable inflation situation. The article also highlights the performance of the Russell 2000 ETF (IWM) and the SPDR ETF (XLC), suggesting a low risk appetite and potential continuation to the downside.

Portfolio Pulse from Thrash Capital

October 31, 2023 | 1:30 pm

BABA

BIDU

EIS

GLD

The ongoing Israel-Hamas conflict has entered its 25th day, with Israeli troops advancing into the Gaza Strip. Chinese tech giants Baidu Inc. and Alibaba Group Holding Ltd. have removed references to Israel from their online maps. The iShares MSCI Israel ETF had its most successful session of 2023, surging by as much as 4.2% on Monday. Gold, as tracked by the SPDR Gold Trust, was little moved, up 0.1% to $2,000/oz.

Portfolio Pulse from Piero Cingari

October 31, 2023 | 1:29 pm

VVPR

VivoPower International PLC (NASDAQ: VVPR) has approved an action plan to address alleged illegal market manipulation, including false information dissemination and naked short selling of its stock. The company has created a Board-led 'Illegal Market Manipulation Task Force' to work with regulators in identifying and prosecuting those involved in market manipulation of VivoPower shares over the past year. VivoPower has engaged an external forensic investigation firm and specialist UK and US legal counsel.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:27 pm

ALNPY

EADSY

RTX

ANA Holdings Inc. plans to inspect Pratt & Whitney's PW1100G-JM engines installed on Airbus SE’s A320neo and A321neo aircraft due to potential issues in the manufacturing of internal engine parts. The inspections will lead to a reduction of approximately 30 flights per day from January to March 2024. RTX Corp, the parent company of Pratt & Whitney, saw its shares close lower by 0.75%.

Portfolio Pulse from Shivani Kumaresan

October 31, 2023 | 1:26 pm

ANVS

Annovis Bio Inc (ANVS) announced a public offering of 1.25 million units, each consisting of one common stock share and one warrant to purchase an additional common stock share. The combined price for each unit is $6.00, with an expected gross proceeds of approximately $7.5 million. The offering is set to close around November 2, with Canaccord Genuity serving as the primary bookrunner. This news led to a 17.9% drop in ANVS shares to $6.69, hitting a new 52-week low.

Portfolio Pulse from Henry Khederian

October 31, 2023 | 1:23 pm

ANVS

Annovis Bio has announced the pricing of a $7.5 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:23 pm

KTRA

Kintara Therapeutics Inc's stock has dropped by 69.2% after the company announced that their drug VAL-083 did not outperform existing treatments for glioblastoma. As a result, the company is discontinuing the development of VAL-083 and shifting focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value. Further data on VAL-083 is expected in 2024, while a study for REM-001 in cutaneous metastatic breast cancer is planned for the end of 2023.

Portfolio Pulse from Henry Khederian

October 31, 2023 | 1:21 pm